pramipexole (Mirapex, Mirapex ER) (cont.)

Pharmacy Author:
Medical and Pharmacy Editor:

PREGNANCY: Pramipexole has not been adequately evaluated in pregnant women. Due to the lack of conclusive safety data, pramipexole should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus. Pramipexole is classified as FDA pregnancy risk category C.

NURSING MOTHERS: It is not known if pramipexole is excreted in breast milk. Due to the lack of conclusive safety data, pramipexole should be used cautiously in females who are breastfeeding.

REFERENCE: FDA Prescribing Information.


Medically Reviewed by a Doctor on 12/3/2014


Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.


Back to Medications Index